Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer (vol 78, pg 2383, 2018)

被引:4
作者
Brand, Toni M.
Hartmann, Stefan
Bhola, Neil E.
Li, Hua
Zeng, Yan
O'Keefe, Rachel A.
V. Ranall, Max
Bandyopadhyay, Sourav
Soucheray, Margaret
Krogan, Nevan J.
Kemp, Carolyn
Duvvuri, Umamaheswar
LaVallee, Theresa
Johnson, Daniel E.
Ozbun, Michelle A.
Bauman, Julie E.
Grandis, Jennifer R.
机构
关键词
D O I
10.1158/0008-5472.CAN-22-1308
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:3187 / 3187
页数:1
相关论文
共 2 条
  • [1] Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer
    Brand, Toni M.
    Hartmann, Stefan
    Bhola, Neil E.
    Li, Hua
    Zeng, Yan
    O'Keefe, Rachel A.
    Ranall, Max, V
    Bandyopadhyay, Sourav
    Soucheray, Margaret
    Krogan, Nevan J.
    Kemp, Carolyn
    Duvvuri, Umamaheswar
    LaVallee, Theresa
    Johnson, Daniel E.
    Ozbun, Michelle A.
    Bauman, Julie E.
    Grandis, Jennifer R.
    [J]. CANCER RESEARCH, 2022, 82 (17) : 3188 - 3188
  • [2] Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer
    Brand, Toni M.
    Hartmann, Stefan
    Bhola, Neil E.
    Li, Hua
    Zeng, Yan
    O'Keefe, Rachel A.
    Ranall, Max V.
    Bandyopadhyay, Sourav
    Soucheray, Margaret
    Krogan, Nevan J.
    Kemp, Carolyn
    Duvvuri, Umamaheswar
    LaVallee, Theresa
    Johnson, Daniel E.
    Ozbun, Michelle A.
    Bauman, Julie E.
    Grandis, Jennifer R.
    [J]. CANCER RESEARCH, 2018, 78 (09) : 2383 - 2395